1-3 of 3
Hanyun Ren, MD PhD
Close
Sort by
Journal Articles

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Yuan Li, MD, Qing Ya Wang, MD, Ze Yin Liang, Yue Yin, Wei Liu, MD PhD, Qian Wang, Yujun Dong, MD, YuHua Sun, Wei Lin Xu, Hanyun Ren, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5647.
https://doi.org/10.1182/blood-2019-125275
Published: 2019
Journal Articles

T Cell Dysfunction in Epstein-Barr Virus-Associated Lymphoma

Huihui Liu, PhD, Xinan Cen, MD, Lihong Wang, MD, Bingjie Wang, MD, Yujun Dong, MD, Yongjin Shi, Bo Tang, MD, Yang Zhang, Wenjun Mao, Junhui Xu, Ye Shen, Hanyun Ren, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5310.
https://doi.org/10.1182/blood-2018-99-119036
Published: 2018
Journal Articles

Homoharringtonine-Based Induction Regimens for Patients with De Novo Acute Myeloid Leukemia: A Multicenter Randomized Controlled Phase 3 Trial

Jie Jin, MD, Jianxiang Wang, Feifei Chen, Depei Wu, MD, Jiong Hu, Jianfeng Zhou, Jianda Hu, MD, Jianmin Wang, Jianyong Li, MD, PhD, Xiaojun Huang, MD, Jun Ma, Chunyan Ji, MD, PhD, Xiaoping Xu, Kang Yu, Hanyun Ren, MD, PhD, Yuhong Zhou, Yin Tong, MD, Yingchang Mi, M.D., Ph.D., Xin Du, PhD, Baoan Chen, Zhu Chen, Sai-Juan Chen
Journal: Blood
Blood (2012) 120 (21): 45.
https://doi.org/10.1182/blood.V120.21.45.45
Published: 2012